Literature DB >> 21402545

A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese.

Ping An1, Cheryl Winkler, Li Guan, Stephen J O'Brien, Zheng Zeng.   

Abstract

A recent genome-wide study showed that the single nucleotide polymorphisms (SNPs) in the HLA-DP region were associated with chronic hepatitis B virus (HBV) infection in Japanese and Thai persons. We tested the effects of HLA-DP SNPs for all major HBV outcomes in Han Chinese (n = 1742): HBV resistance, clearance, chronic infection, cirrhosis, and hepatocellular carcinoma. HLA - DPA1 rs3077 T was strongly associated with decreased risk of chronic HBV infection (odds ratio, .62; P = .001), consistent with the previous report. We showed for the first time to our knowledge that it is a predictor for HBV clearance (odds ratio, 2.41; P < .001). However, rs3077 was not associated with the development of cirrhosis or hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402545      PMCID: PMC3068033          DOI: 10.1093/infdis/jiq154

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.

Authors:  W L Alward; B J McMahon; D B Hall; W L Heyward; D P Francis; T R Bender
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

2.  Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection.

Authors:  H C Thomas; G R Foster; M Sumiya; D McIntosh; D L Jack; M W Turner; J A Summerfield
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

3.  Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins.

Authors:  Thomas Höhler; Esther Reuss; Nina Evers; Evi Dietrich; Christian Rittner; Christine M Freitag; Jens Vollmar; Peter M Schneider; Rolf Fimmers
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

4.  Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers.

Authors:  M W Yu; F C Hsu; I S Sheen; C M Chu; D Y Lin; C J Chen; Y F Liaw
Journal:  Am J Epidemiol       Date:  1997-06-01       Impact factor: 4.897

Review 5.  Global epidemiology of hepatitis B virus.

Authors:  Brian Custer; Sean D Sullivan; Thomas K Hazlet; Uchenna Iloeje; David L Veenstra; Kris V Kowdley
Journal:  J Clin Gastroenterol       Date:  2004 Nov-Dec       Impact factor: 3.062

6.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia.

Authors:  M R Thursz; D Kwiatkowski; C E Allsopp; B M Greenwood; H C Thomas; A V Hill
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

7.  HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up.

Authors:  Chia-Ming Chu; Yun-Fan Liaw
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

8.  HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

Authors:  Man-Fung Yuen; Danny Ka-Ho Wong; Erwin Sablon; Eric Tse; Irene Oi-Lin Ng; He-Jun Yuan; Chung-Wah Siu; Tamara J Sander; Eric J Bourne; Jeff G Hall; Lynn D Condreay; Ching-Lung Lai
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

9.  Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection.

Authors:  Chloe L Thio; David L Thomas; Peter Karacki; Xiaojiang Gao; Darlene Marti; Richard A Kaslow; James J Goedert; Margaret Hilgartner; Steffanie A Strathdee; Priya Duggal; Stephen J O'Brien; Jacquie Astemborski; Mary Carrington
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

Authors:  Xiaofeng Liang; Shengli Bi; Weizhong Yang; Longde Wang; Gang Cui; Fuqiang Cui; Yong Zhang; Jianhua Liu; Xiaohong Gong; Yuansheng Chen; Fuzhen Wang; Hui Zheng; Feng Wang; Jing Guo; Zhiyuan Jia; Jingchen Ma; Huaqing Wang; Huiming Luo; Li Li; Shuigao Jin; Stephen C Hadler; Yu Wang
Journal:  Vaccine       Date:  2009-09-01       Impact factor: 3.641

View more
  27 in total

1.  HLA class II associated with outcomes of hepatitis B and C infections.

Authors:  Akihiro Tamori; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  Treatment of hepatitis B virus: an update.

Authors:  Haley Ward; Lydia Tang; Bhawna Poonia; Shyam Kottilil
Journal:  Future Microbiol       Date:  2016-11-18       Impact factor: 3.165

3.  HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.

Authors:  Qi Zhang; Jianhua Yin; Yuwei Zhang; Yang Deng; Xiaowei Ji; Yan Du; Rui Pu; Yifang Han; Jun Zhao; Xue Han; Hongwei Zhang; Guangwen Cao
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

4.  New Gene Variants Associated with the Risk of Chronic HBV Infection.

Authors:  Mengjie Fan; Jing Wang; Sa Wang; Tengyan Li; Hong Pan; Hankui Liu; Huifang Xu; Daria V Zhernakova; Stephen J O'Brien; Zhenru Feng; Le Chang; Erhei Dai; Jianhua Lu; Hongli Xi; Yanyan Yu; Jianguo Zhang; Binbin Wang; Zheng Zeng
Journal:  Virol Sin       Date:  2020-04-15       Impact factor: 4.327

5.  The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression.

Authors:  Ping An; Zheng Zeng; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

6.  New loci associated with chronic hepatitis B virus infection in Han Chinese.

Authors:  Zhibin Hu; Yao Liu; Xiangjun Zhai; Juncheng Dai; Guangfu Jin; Li Wang; Liguo Zhu; Yuan Yang; Jibin Liu; Minjie Chu; Juan Wen; Kaipeng Xie; Guoming Du; Qungang Wang; Yuchun Zhou; Minquan Cao; Li Liu; Yisha He; Ying Wang; Gangqiao Zhou; Weihua Jia; Jiachun Lu; Shengping Li; Jianjun Liu; Haitao Yang; Yongyong Shi; Weiping Zhou; Hongbing Shen
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

Review 7.  Human genes involved in hepatitis B virus infection.

Authors:  Zheng Zeng
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

8.  Strategies to eliminate HBV infection.

Authors:  Rama Kapoor; Shyam Kottilil
Journal:  Future Virol       Date:  2014       Impact factor: 1.831

Review 9.  Theoretical basis of a beneficial role for vitamin D in viral hepatitis.

Authors:  Khanh vinh quốc Lương; Lan Thi Hoàng Nguyễn
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

Review 10.  Human genetic susceptibility to infectious disease.

Authors:  Stephen J Chapman; Adrian V S Hill
Journal:  Nat Rev Genet       Date:  2012-02-07       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.